Our recent randomized controlled study has also reported that oral vitamin C supplementation of 1,000 mg/day was associated with increased concentration of plasma vitamin C and adiponectin as well as improved glucose metabolism and liver function in patients with NAFLD. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.